Cite

HARVARD Citation

    Yan, J. et al. (2018). Analysis of NRAS gain in 657 patients with melanoma and evaluation of its sensitivity to a MEK inhibitor. European journal of cancer. pp. 90-101. [Online]. 
  
Back to record